[Myasthenia gravis: pathogenesis]. 1979

B W Fulpius

UI MeSH Term Description Entries
D009157 Myasthenia Gravis A disorder of neuromuscular transmission characterized by fatigable weakness of cranial and skeletal muscles with elevated titers of ACETYLCHOLINE RECEPTORS or muscle-specific receptor tyrosine kinase (MuSK) autoantibodies. Clinical manifestations may include ocular muscle weakness (fluctuating, asymmetric, external ophthalmoplegia; diplopia; ptosis; and weakness of eye closure) and extraocular fatigable weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles (ocular myasthenia). THYMOMA is commonly associated with this condition. Anti-MuSK Myasthenia Gravis,MuSK MG,MuSK Myasthenia Gravis,Muscle-Specific Receptor Tyrosine Kinase Myasthenia Gravis,Muscle-Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis,Myasthenia Gravis, Generalized,Myasthenia Gravis, Ocular,Anti MuSK Myasthenia Gravis,Generalized Myasthenia Gravis,Muscle Specific Receptor Tyrosine Kinase Myasthenia Gravis,Muscle Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis,Myasthenia Gravis, Anti-MuSK,Myasthenia Gravis, MuSK,Ocular Myasthenia Gravis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

B W Fulpius
November 2006, No to shinkei = Brain and nerve,
B W Fulpius
October 1971, British medical journal,
B W Fulpius
May 1971, British medical journal,
B W Fulpius
June 1971, British medical journal,
B W Fulpius
May 1971, British medical journal,
B W Fulpius
April 1971, British medical journal,
B W Fulpius
January 2000, Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion,
B W Fulpius
January 1978, Muscle & nerve,
B W Fulpius
May 1997, Virchows Archiv : an international journal of pathology,
B W Fulpius
June 1994, Seminars in neurology,
Copied contents to your clipboard!